Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2007
11/08/2007US20070259120 Addition compounds as dispersants and dispersion stabilizers
11/08/2007US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007CA2649249A1 Low triphenylphosphate, high phosphorous content isopropyl phenyl phosphates with high ortho alkylation
11/08/2007CA2649072A1 Crystalline forms of ibandronic acid and processes for preparation thereof
11/08/2007CA2647316A1 Process for preparation of hiv protease inhibitors
11/07/2007EP1852427A1 Biologically active 4H-Benzo [1,4] oxazin-3-ones
11/07/2007EP1852121A2 Lipid analogs for treating viral infections
11/07/2007EP1851276A1 Use of dithiophosphinic acid and/or its salts for producing anti-corrosion coatings that are devoid of chrome
11/07/2007EP1851234A1 Substituted propane phosphinic acid esters
11/07/2007EP1851233A1 Method for producing tertiary phosphines
11/07/2007EP1812452A4 Thermosensitive and biocompatible amphiphilic cyclic phosphazene trimer and preparation method thereof
11/07/2007CN101068791A Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
11/07/2007CN101066981A Non-cyclic nucleoside phosphonate compound and its composition, prepn process and use
11/07/2007CN101066980A Crystalline tenofovir fumarate and its medicine prepn
11/07/2007CN101066979A Industrial production process of extracting high purity lecithin
11/07/2007CN100347185C Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
11/07/2007CN100347151C Novel aminobenzoephenones
11/06/2007US7291751 Catalysis of N-(phosphonomethyl)iminodiacetic acid, formaldehyde, and formic acid with a catalyst of iron, cobalt, and platinum, palladium, ruthenium, rhodium, iridium, silver, osmium, or gold; supplemental promoter of bismuth or tellurium
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/01/2007WO2007123957A2 Bisphospholanes for use as catalysts in asymmetric reactions
11/01/2007WO2007122847A1 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
11/01/2007WO2007109542A3 Process for manufacturing bisphosphonic acids
11/01/2007WO2007081755A3 Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
11/01/2007WO2007077240A3 Functionalised nanoparticles, their production and use
11/01/2007WO2006116057A3 Facilitated transport of bisphosphonates by vitamin c
11/01/2007US20070254991 Phosphorus-containing tetrabromobisphenol A
11/01/2007US20070253940 Composition Comprising Platelet-Rich Plasma
10/2007
10/31/2007EP1849790A2 Diazaphosphacycles
10/31/2007EP1849789A1 Metal complexes of polydentate beta-ketoiminates
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1848728A1 Ibandronate polymorph a
10/31/2007EP1848727A1 Ibandronate polymorph b
10/31/2007EP1745056A4 Enantioselective phosphoramidite compounds and catalysts
10/31/2007EP1687638B1 Analysis of mass spectral data in the quiet zones
10/31/2007EP1360168A4 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
10/31/2007EP1178994B1 Improved process for phosphorylation
10/31/2007CN101065388A Process for preparing acylphosphanes and derivatives thereof
10/31/2007CN101065387A Composition containing phosphorylcholine and preparing method thereof
10/31/2007CN101065330A Chelating agents for heavy metal removal
10/31/2007CN101062043A Application of 3, 4, 5, 4'-tetramethyl diphenylethane-3'-O-disodium phosphate in the anti-cancer medicine and the transferring medicine thereof
10/31/2007CN100345895C Higher alkylated triaryl phosphate ester flame retardants
10/31/2007CN100345635C Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
10/30/2007US7288679 Organophosphonium transition metal dye provided with filter; scanner, a digitizer, a display and photographic devices; medical diagnostic systems; optics
10/30/2007US7288673 Salts of substituted methylene bisphosphonic acids
10/30/2007US7288666 High metathesis activity ruthenium and osmium metal carbene complexes
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007CA2419485C Recyclable metathesis catalysts
10/30/2007CA2231588C Process for the preparation of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-.alpha.,.alpha.-dimethylphenylacetic acid and phosphorylated derivatives
10/30/2007CA2091663C Cyclic peptide antifungal agents and process for preparation thereof
10/25/2007WO2007119816A1 Organic electroluminescence element material, organic electroluminescence element, display device and lighting apparatus
10/25/2007WO2007119027A1 Calixarene derivatives as anticancer agent
10/25/2007WO2007118817A1 Coupling compounds and hair dyeing compositions containing them
10/25/2007WO2007064871A3 Diagnostic and treatment regimen for achieving body water homeostasis
10/25/2007WO2007052169A3 Hypophosphorous acid derivatives and their therapeutical applications
10/25/2007US20070249871 Process of Preparing Glycolaldehyde
10/25/2007US20070249837 reaction of a alpha - beta -unsaturated carbonyl compound with a Wittig reagent or Horner-Wadsworth-Emmons reagent in the presence of a base; regioselective; sulfonamide type herbicides; 5,5-Diethoxy-2-thiomethyl-3-trifluoromethyl-pent-2-ene-nitrile
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249565 Class of Gamma Delta T Cells Activators and Use Thereof
10/25/2007US20070249564 Novel phosphorus-containing prodrugs
10/25/2007US20070249563 Reacting a 3-trichloromethyliminooxymethyl-5,5-diphenylhydantoin compound with dibenzyl phosphate, and hydrogenolysis of the benzyl ester
10/25/2007US20070247063 Light-Emitting Device Material and Light-Emitting Device
10/25/2007CA2649836A1 Calixarene derivatives as anticancer agent
10/24/2007EP1847563A2 Antistatic and antidust agents, compositions thereof, and methods of manufacture
10/24/2007EP1847539A1 Quinazoline derivatives
10/24/2007EP1847528A1 Coupling compounds and hair dyeing compositions containing them
10/24/2007EP1846406A1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
10/24/2007EP1846350A2 Improved method for the preparation of enantiomerically enriched secondary alcohols by the addition of organoaluminium reagents to carbonyl compounds
10/24/2007EP1845981A1 Synthesis of sodium narcistatin and related compounds
10/24/2007EP1628647A4 Novel lipids for transfection of nucleic acids
10/24/2007EP1399454B1 Heterocyclically substituted (thio)phosphoric triamides
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007CN200964388Y Preparation device for acetyl chloride cogeneration hydroxyl ethidene diphosphoric acid
10/24/2007CN101061128A Process for preparing di-isopropyl ((1(hydroxymethyl)-cyclopropyl)oxy) methylphosphonate
10/24/2007CN101061127A 1,4-hydroquinone functionalized phosphinates and phosphonates
10/24/2007CN101058589A Method of synthesizing ifosfamide
10/24/2007CN101058588A Method of Synthesizing adefovir dipivoxil
10/24/2007CN101058587A Bi(4-(4-fluorobenzoyl)phenyl)phenyl phosphine oxide monomer and synthetic method thereof
10/24/2007CN101058586A Method of concentrating and separating glyphosate in high salt content glyphosate mother liquor by film technique
10/24/2007CN100344647C Marking method and selective adsorption method for phosphorylating peptide, coordination compound used for the same method and producing method for the same coordination compound
10/24/2007CN100344640C Process for preparing haptens for immunoassay of phosphorothioate pesticides
10/24/2007CN100344639C Method for phosphatide extraction from soybean vegetable oil
10/24/2007CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007CN100344380C Room temperature ionic liquid and its preparation method
10/23/2007US7285673 Process for fluoro derivative-substituted aryl pnictogens and their oxides
10/23/2007US7285658 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions
10/23/2007US7285610 Forming low polydispersity polymers; controlled number-average molar masses, Mn; block polymers; phosphonate-substituted xanthates such as 2-(1-diethoxyphosphoryl)-(ethoxythiocarbonylsulfanyl)-propionic acid ethyl ester
10/23/2007US7285572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
10/23/2007US7285543 Purine inhibitors of fructose-1,6-bisphosphatase
10/23/2007US7285422 Depositing a defined and controlled 0.2 to 20 nanoliter volume of a solution of 3-hydroxypicolinic acid matrix, an evaporating solvent and no analyte at a plurality of discrete locations on the surface of a substrate by an automated dispenser; evaporating the solvent, forming array of spots on surface
10/23/2007CA2334151C Catalyst comprising a complex of a metal from subgroup viii based on a bidentate phosphonite ligand, and method for producing nitriles
10/23/2007CA2217780C Polyether nucleic acids
10/18/2007WO2007116081A1 Ferrocenediphosphines
10/18/2007WO2007085326A3 Abrasion resistant coated wire
10/18/2007WO2007082104A3 Compounds and methods for the treatment of cancer
10/18/2007WO2007063509A3 Phosphocreatine complexes
10/18/2007US20070244342 Process for Preparing Solid Particles of Phenolic Antioxidants
10/18/2007US20070244076 Site and Rate Selective Prodrug Formulations of D609 with Antioxidant and Anticancer Activity
10/18/2007US20070244075 Isoflavonoid Prodrugs, Compositons Thereof and Therapeutic Methods Involving Same